Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-08

Clinical Trial Update: Probiotic Lactobacillus Reuteri and Oral Microbiota [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the probiotic Lactobacillus reuteri for effects on the oral microbiota and dental plaque has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus reuteri (Lactobacillus reuteri)

Snippet

Sponsor: Umeå University | Conditions: Dental Plaque | Phase 2 | Status: COMPLETED